en fr

About Us
Portfolio and Disease Areas
Investors
News and Events
Contact Us

Bausch + Lomb Initiates Phase 3 Program for Glaucoma Drug Candidate Licensed from Nicox

January 28, 2013

← Back to blog page

Contact Us
Subscribe to news
Legal Notice

© Copyright Nicox, all rights reserved

Cookies

By continuing to use this website, you agree to our Cookie Policy.